drugset / Trial / NCT01534208
Safety Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism
Non-randomizedParallel-groupOpen-labelTreatment
Summary
ZA-300 is meant to determine the safety profile of Androxal (enclomiphene citrate) in men with secondary hypogonadism.
Timeline
- Start
- 2012-05
- Primary completion
- 2013-10
- Completion
- 2013-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Androxal | Unknown | 12.5 mg | Oral |
| Subject | Androxal | Unknown | 25 mg | Oral |